Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis. (Q48273440)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Michele Zoli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

PierFranco Spano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

6

Andreas Heinz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Martina Ballmaier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Cristina Rizzetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

GianLuigi Gessa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

14 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

2098-2107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299506%20AND%20SRC:MED&resulttype=core&format=json

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Anxiolytic-like properties of the anandamide transport inhibitor AM404.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

The NMDA positive modulator D-cycloserine inhibits dopamine-mediated behaviors in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

A cannabinoid mechanism in relapse to cocaine seeking.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Animal behavior models of the mechanisms underlying antipsychotic atypicality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

The endophenotype concept in psychiatry: etymology and strategic intentions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Cannabis use and psychosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Is cannabis use psychotogenic?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Molecular brain imaging and the neurobiology and genetics of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

An endocannabinoid mechanism for stress-induced analgesia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Molecular composition of the endocannabinoid system at glutamatergic synapses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

"Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Disorders of attention and perception in early schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Glutamatergic animal models of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

A rat model of phencyclidine psychosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

The molecular logic of endocannabinoid signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Cannabis as a risk factor for psychosis: systematic review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021

Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301344

7 January 2021